Category: Clinical Studies

  • AB Science Holds the Clinical Studies of Masitinib Globally

    Shots: The company holds the inclusion and initiation of treatment in ongoing 3 studies i.e P-III in mastocytosis (AB15003), P-III study in AML (AB19001) & P-II in COVID (AB20001) for masitinib, until the investigation of safety issue is completed The decision follows discussions with the French regulatory authorities (ANSM) and other regulatory agencies. The company […]